Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Non-Squamous Non-Small Cell Carcinoma × zipalertinib × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Lung Non-Squamous Non-Small Cell Carcinoma 1 Lung Neoplasms 1 Carcinoma 1

Interventions

zipalertinib 1 Specimen Handling 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07229339 2026-02-05

Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Not yet recruiting

Lung Non-Squamous Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡